TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/20/22 16:05 | 4/19/22 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Subramanian Sanjay | MA | O | SVP,CFO | P | 100 | 3.69 | 0 | 27 | New | 27 | D | ||||||||||||||
11/26/19 19:17 | 11/22/19 | OCGN | Ocugen, Inc. | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Subramanian Sanjay | PA | O | CFO | P | 1 | 0.2800 | 0 | 5 | 100 | 10 | D | ||||||||||||||
10/4/19 13:36 | 10/2/19 | OCGN | Ocugen, Inc. | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Subramanian Sanjay | PA | O | CFO | P.d | 9 | 1.88 | 0 | 5 | New | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |